Comparative Study of the Effects of Sublingual Trinitroglycerin and Sublingual Misoprostol on Cervical Preparation before Hysteroscopy: A Randomized Controlled Trial

Background: Hysteroscopy is a valuable surgical technique, but some complications are related to cervical dilatation. Sublingual trinitroglycerin (TNG) is a vasodilator that can facilitate cervical dilation. In our study, we compared its effectiveness to that of misoprostol. Methods: This randomized...

Full description

Saved in:
Bibliographic Details
Main Authors: Shahla Mirgaloybayat, Mahmoodreza Madadian, Kobra Tahermanesh, Roya Derakhshan, Saeedeh Sarhadi, Samaneh Rokhgireh
Format: Article
Language:English
Published: IMR Press 2024-07-01
Series:Clinical and Experimental Obstetrics & Gynecology
Subjects:
Online Access:https://www.imrpress.com/journal/CEOG/51/7/10.31083/j.ceog5107167
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849683254123167744
author Shahla Mirgaloybayat
Mahmoodreza Madadian
Kobra Tahermanesh
Roya Derakhshan
Saeedeh Sarhadi
Samaneh Rokhgireh
author_facet Shahla Mirgaloybayat
Mahmoodreza Madadian
Kobra Tahermanesh
Roya Derakhshan
Saeedeh Sarhadi
Samaneh Rokhgireh
author_sort Shahla Mirgaloybayat
collection DOAJ
description Background: Hysteroscopy is a valuable surgical technique, but some complications are related to cervical dilatation. Sublingual trinitroglycerin (TNG) is a vasodilator that can facilitate cervical dilation. In our study, we compared its effectiveness to that of misoprostol. Methods: This randomized controlled trial study was conducted on 199 women of reproductive age who were referred to Rasoul Akram Hospital. Patients were randomly divided into two groups: TNG and misoprostol. Next, they were examined for clinical and practical indicators of cervical preparation. The data was analyzed using SPSS software. Results: Demographic characteristics exhibited no significant differences between the groups. The mean size of the largest dilator inserted without resistance showed not statistically significant difference between the TNG and misoprostol groups (6.26 ± 1.95 vs. 6.57 ± 2.05; p = 0.20). Side effects were reported in 66 (33.2%) of the women studied. The misoprostol group experienced a significantly higher rate of side effects (53.7%) compared to the TNG group (14.4%; p < 0.001). The most frequently observed side effect in the TNG group was headache, which occurred at a statistically significantly higher rate than in the misoprostol group (p = 0.04). On the other hand, uterine bleeding before hysteroscopy was significantly lower in the TNG group compared to the misoprostol group (p < 0.001). Conclusions: There was no statistically significant difference in the mean size of the largest dilator inserted without resistance between the TNG and misoprostol groups. Additionally, TNG experienced significantly fewer side effects than sublingual misoprostol group, with headache being the most prominent side effect. Sublingual TNG can be used to improve cervical preparation before hysteroscopy. Clinical Trial Registration: The study has been registered on https://trialsearch.who.int/Trial2.aspx?TrialID=IRCT20191123045476N4 (registration number: IRCT20191123045476N4).
format Article
id doaj-art-dc0cd9a60fef4d5991b7002a5cb6b2e0
institution DOAJ
issn 0390-6663
language English
publishDate 2024-07-01
publisher IMR Press
record_format Article
series Clinical and Experimental Obstetrics & Gynecology
spelling doaj-art-dc0cd9a60fef4d5991b7002a5cb6b2e02025-08-20T03:23:57ZengIMR PressClinical and Experimental Obstetrics & Gynecology0390-66632024-07-0151716710.31083/j.ceog5107167S0390-6663(24)02403-5Comparative Study of the Effects of Sublingual Trinitroglycerin and Sublingual Misoprostol on Cervical Preparation before Hysteroscopy: A Randomized Controlled TrialShahla Mirgaloybayat0Mahmoodreza Madadian1Kobra Tahermanesh2Roya Derakhshan3Saeedeh Sarhadi4Samaneh Rokhgireh5Department of Obstetrics and Gynecology, School of Medicine, Iran University of Medical Sciences, 1449614535 Tehran, IranDepartment of Faculty of Pharmacy, Islamic Azad University, 1941933111 Tehran, IranEndometriosis Research Center, Iran University of Medical Sciences, 1449614535 Tehran, IranEndometriosis Research Center, Iran University of Medical Sciences, 1449614535 Tehran, IranHealth Promotion Research Center, Zahedan University of Medical Sciences, 9816743463 Zahedan, IranEndometriosis Research Center, Iran University of Medical Sciences, 1449614535 Tehran, IranBackground: Hysteroscopy is a valuable surgical technique, but some complications are related to cervical dilatation. Sublingual trinitroglycerin (TNG) is a vasodilator that can facilitate cervical dilation. In our study, we compared its effectiveness to that of misoprostol. Methods: This randomized controlled trial study was conducted on 199 women of reproductive age who were referred to Rasoul Akram Hospital. Patients were randomly divided into two groups: TNG and misoprostol. Next, they were examined for clinical and practical indicators of cervical preparation. The data was analyzed using SPSS software. Results: Demographic characteristics exhibited no significant differences between the groups. The mean size of the largest dilator inserted without resistance showed not statistically significant difference between the TNG and misoprostol groups (6.26 ± 1.95 vs. 6.57 ± 2.05; p = 0.20). Side effects were reported in 66 (33.2%) of the women studied. The misoprostol group experienced a significantly higher rate of side effects (53.7%) compared to the TNG group (14.4%; p < 0.001). The most frequently observed side effect in the TNG group was headache, which occurred at a statistically significantly higher rate than in the misoprostol group (p = 0.04). On the other hand, uterine bleeding before hysteroscopy was significantly lower in the TNG group compared to the misoprostol group (p < 0.001). Conclusions: There was no statistically significant difference in the mean size of the largest dilator inserted without resistance between the TNG and misoprostol groups. Additionally, TNG experienced significantly fewer side effects than sublingual misoprostol group, with headache being the most prominent side effect. Sublingual TNG can be used to improve cervical preparation before hysteroscopy. Clinical Trial Registration: The study has been registered on https://trialsearch.who.int/Trial2.aspx?TrialID=IRCT20191123045476N4 (registration number: IRCT20191123045476N4).https://www.imrpress.com/journal/CEOG/51/7/10.31083/j.ceog5107167cervical ripeningmisoprostolhysteroscopytrinitroglycerin
spellingShingle Shahla Mirgaloybayat
Mahmoodreza Madadian
Kobra Tahermanesh
Roya Derakhshan
Saeedeh Sarhadi
Samaneh Rokhgireh
Comparative Study of the Effects of Sublingual Trinitroglycerin and Sublingual Misoprostol on Cervical Preparation before Hysteroscopy: A Randomized Controlled Trial
Clinical and Experimental Obstetrics & Gynecology
cervical ripening
misoprostol
hysteroscopy
trinitroglycerin
title Comparative Study of the Effects of Sublingual Trinitroglycerin and Sublingual Misoprostol on Cervical Preparation before Hysteroscopy: A Randomized Controlled Trial
title_full Comparative Study of the Effects of Sublingual Trinitroglycerin and Sublingual Misoprostol on Cervical Preparation before Hysteroscopy: A Randomized Controlled Trial
title_fullStr Comparative Study of the Effects of Sublingual Trinitroglycerin and Sublingual Misoprostol on Cervical Preparation before Hysteroscopy: A Randomized Controlled Trial
title_full_unstemmed Comparative Study of the Effects of Sublingual Trinitroglycerin and Sublingual Misoprostol on Cervical Preparation before Hysteroscopy: A Randomized Controlled Trial
title_short Comparative Study of the Effects of Sublingual Trinitroglycerin and Sublingual Misoprostol on Cervical Preparation before Hysteroscopy: A Randomized Controlled Trial
title_sort comparative study of the effects of sublingual trinitroglycerin and sublingual misoprostol on cervical preparation before hysteroscopy a randomized controlled trial
topic cervical ripening
misoprostol
hysteroscopy
trinitroglycerin
url https://www.imrpress.com/journal/CEOG/51/7/10.31083/j.ceog5107167
work_keys_str_mv AT shahlamirgaloybayat comparativestudyoftheeffectsofsublingualtrinitroglycerinandsublingualmisoprostoloncervicalpreparationbeforehysteroscopyarandomizedcontrolledtrial
AT mahmoodrezamadadian comparativestudyoftheeffectsofsublingualtrinitroglycerinandsublingualmisoprostoloncervicalpreparationbeforehysteroscopyarandomizedcontrolledtrial
AT kobratahermanesh comparativestudyoftheeffectsofsublingualtrinitroglycerinandsublingualmisoprostoloncervicalpreparationbeforehysteroscopyarandomizedcontrolledtrial
AT royaderakhshan comparativestudyoftheeffectsofsublingualtrinitroglycerinandsublingualmisoprostoloncervicalpreparationbeforehysteroscopyarandomizedcontrolledtrial
AT saeedehsarhadi comparativestudyoftheeffectsofsublingualtrinitroglycerinandsublingualmisoprostoloncervicalpreparationbeforehysteroscopyarandomizedcontrolledtrial
AT samanehrokhgireh comparativestudyoftheeffectsofsublingualtrinitroglycerinandsublingualmisoprostoloncervicalpreparationbeforehysteroscopyarandomizedcontrolledtrial